New Hampshire Trust’s Sanofi SNY Stock Holding History

New Hampshire Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$27.2K	–	308
2023 Q1	$27.2K	Hold	500	–	–	0.01%	289
2022 Q4	$24.2K	Buy	+500	New	+$21.9K	0.01%	297

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

New Hampshire Trust's SNY Position: Q2 2023 in Review

New Hampshire Trust sold out of Sanofi (SNY) in Q2 2023, closing a stake of 500 shares — an estimated $27.2K sold.

New Hampshire Trust first reported a position in SNY in Q4 2022 and held it in 2 quarters. The position peaked at $27.2K in Q1 2023. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

New Hampshire Trust reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
New Hampshire Trust sold 500 Sanofi shares in Q2 2023, an estimated $27.2K.
New Hampshire Trust first reported a position in Sanofi in Q4 2022 and held it in 2 quarters.
New Hampshire Trust's Sanofi position peaked at $27.2K in Q1 2023.
672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on New Hampshire Trust's 13F filing for Q2 2023, filed 11 Jul 2023.